Last $55.26 USD
Change Today +1.15 / 2.13%
Volume 456.4K
ALNY On Other Exchanges
As of 5:20 PM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - alnylam pharmaceuticals inc (ALNY)

NameBoard RelationshipsTitleAge
John M. Maraganore M.D., Ph.D.171 RelationshipsChief Executive Officer and Executive Director51
Barry E. Greene 40 RelationshipsPresident and Chief Operating Officer51
John K. Clarke 113 RelationshipsFounder, Chairman, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee60
Michael P. Mason No RelationshipsPrincipal Financial Officer, Principal Accounting Officer, Vice President of Finance and Treasurer39
Oved Amity No RelationshipsHead of Commercial and Vice President--

Board Members - alnylam pharmaceuticals inc (ALNY)

NameBoard RelationshipsPrimary CompanyAge
John K. Clarke 113 RelationshipsAlnylam Pharmaceuticals, Inc.60
John M. Maraganore M.D., Ph.D.171 RelationshipsAlnylam Pharmaceuticals, Inc.51
Phillip A. Sharp Ph.D.142 RelationshipsAmerican Association for the Advancement of Science69
Kevin P. Starr 76 RelationshipsThird Rock Ventures, LLC51
Steven M. Paul M.D.133 RelationshipsSage Therapeutics, Inc.63

Executive Committees* - alnylam pharmaceuticals inc (ALNY)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeKevin P. Starr 76 Relationships3 Executives
Compensation CommitteeSteven M. Paul M.D. 133 Relationships3 Executives
Nominating CommitteeJohn K. Clarke 113 Relationships2 Executives
Corporate Governance CommitteeJohn K. Clarke 113 Relationships2 Executives
View ALNY Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALNY:US $55.26 USD +1.15

ALNY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Enzon Pharmaceuticals Inc $1.05 USD +0.01
Galena Biopharma Inc $2.90 USD +0.105
Regulus Therapeutics Inc $6.88 USD +0.21
Silence Therapeutics PLC 227.50 GBp +6.50
Tekmira Pharmaceuticals Corp C$10.66 CAD +0.38
View Industry Companies

Industry Analysis


Industry Average

Valuation ALNY Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 99.7x
Price/Book 4.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 93.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALNYLAM PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at